Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05641142

Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

Led by University Hospital, Clermont-Ferrand · Updated on 2025-04-09

100

Participants Needed

18

Research Sites

312 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to evaluate in real life, in patients with Hereditary Hemorrhagic Telangiectasia (HHT), the tolerance of the strategy of use of anticoagulant and/or antiplatelet, by comparing a new exposure period (first trimester of treatment) to a period of reference non-exposure (last trimester before start of treatment).

CONDITIONS

Official Title

Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient with Rendu-Osler disease with an indication of antiplatelet and/or anticoagulant introduced for less than 3 months
  • Age > 18 years old
  • Patient able to understand and agree to participate in the study
  • Affiliation to a social security system
Not Eligible

You will not qualify if you...

  • Patient with an indication of antiplatelet and/or anticoagulant but for whom treatment has not been introduced or introduced for more than 3 months
  • Refusal to participate
  • Pregnant woman or who are breast feeding
  • Patients under maintenance of justice, wardship or legal guardianship

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 18 locations

1

CHU d'Angers

Angers, France

Not Yet Recruiting

2

CHU de Bordeaux

Bordeaux, France

Not Yet Recruiting

3

Hôpital Ambroise Paré

Boulogne-Billancourt, France

Not Yet Recruiting

4

CHU de Caen Normandie

Caen, France

Not Yet Recruiting

5

CHU clermont-ferrand

Clermont-Ferrand, France

Actively Recruiting

6

CHU de Dijon

Dijon, France

Not Yet Recruiting

7

CHRU de Lille

Lille, France

Not Yet Recruiting

8

Hospices Civiles de Lyon

Lyon, France

Not Yet Recruiting

9

Assistance Publique - Hôpitaux de Marseille

Marseille, France

Not Yet Recruiting

10

CHU de Montpellier

Montpellier, France

Not Yet Recruiting

11

CHU de Nancy

Nancy, France

Not Yet Recruiting

12

CHU de Nantes

Nantes, France

Not Yet Recruiting

13

CHU de Nice

Nice, France

Not Yet Recruiting

14

AP-HP - Hôpital Ténon

Paris, France

Not Yet Recruiting

15

CHU de Poitiers

Poitiers, France

Not Yet Recruiting

16

CHU de Rennes

Rennes, France

Not Yet Recruiting

17

CHRU de Strasbourg

Strasbourg, France

Not Yet Recruiting

18

CHU de Toulouse

Toulouse, France

Not Yet Recruiting

Loading map...

Research Team

L

Lise Laclautre

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia | DecenTrialz